Skip to main content
Clinical Trials/NCT04306536
NCT04306536
Terminated
Not Applicable

Muscle-targeted Nutritional Support in Post-surgical Rehabilitation for Femur Fracture

Barichella Michela1 site in 1 country20 target enrollmentJune 19, 2020
ConditionsFemur Fracture

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Femur Fracture
Sponsor
Barichella Michela
Enrollment
20
Locations
1
Primary Endpoint
Physical performance - gait speed
Status
Terminated
Last Updated
8 months ago

Overview

Brief Summary

This randomized, observer-blinded trial tested the hypothesis that nutritional supplementation with muscle-target nutritional supplementation would increase the efficacy of a physical rehabilitation program in old adults with femur fracture treated with surgery.

Detailed Description

Muscle-target nutritional supplementation has been domonstrated to enhance the recovery of muscle mass and increase the efficacy of a rehabilitation program in patients suffering from sarcopenia. Femure fracture is responsible for increased immobilization resulting in loss of muscle mass which may be further emphasized by surgical stress. This randomized, observer-blinded trial tested the hypothesis that nutritional supplementation with muscle-target nutritional supplementation would increase the efficacy of a physical rehabilitation program in old adults with femur fracture treated with surgery.

Registry
clinicaltrials.gov
Start Date
June 19, 2020
End Date
December 20, 2020
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Barichella Michela
Responsible Party
Sponsor Investigator
Principal Investigator

Barichella Michela

Study coordinator

ASST Gaetano Pini-CTO

Eligibility Criteria

Inclusion Criteria

  • age 60 years or older
  • admission for physical rehabilitation after surgery for femur fracture
  • informed consent

Exclusion Criteria

  • Any malignant disease during the last five years
  • Known kidney failure (previous glomerular filtration rate \<30 ml/min);
  • Known liver failure (Child B or C)
  • Psychiatric disease
  • Severe cognitive impairment (Mini Mental State Examination \<18)
  • Endocrine disorders associated with disorders of calcium metabolism (excluding osteoporosis)
  • Indications related to the study product:
  • More than 10 µg (400 IU) of daily Vitamin D intake from medical sources
  • More than 500 mg of daily calcium intake from medical sources.
  • Adherence to a high-energy or high-protein diet (up to three months before starting the study)

Outcomes

Primary Outcomes

Physical performance - gait speed

Time Frame: 4 weeks

Gait speed at the 10-meter walking test

Secondary Outcomes

  • Body weight(4 weeks)
  • Body composition - fat-free mass(4 weeks)
  • Body composition - phase angle(4 weeks)
  • Body composition - muscle mass(4 weeks)
  • Body composition - fat-free mass index(4 weeks)
  • Physical performance - Timed Up and Go test(4 weeks)
  • Functional status - Barthel(4 weeks)
  • Functional status - handgrip strength(4 weeks)
  • Calf circumference(4 weeks)
  • Modality of discharge(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials